Piperazine → HCID 59493240, compound
Reaction equation
[CH2:1]([O:3][C:4](=[O:30])[C:5]([CH3:29])([O:22][C:23]1[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=1)[CH2:6][C:7]1[CH:12]=[CH:11][C:10]([O:13][C:14]2[CH:19]=[C:18](Cl)[N:17]=[C:16]([NH2:21])[N:15]=2)=[CH:9][CH:8]=1)[CH3:2].[NH:31]1[CH2:36][CH2:35][NH:34][CH2:33][CH2:32]1>>[CH2:1]([O:3][C:4](=[O:30])[C:5]([CH3:29])([O:22][C:23]1[CH:28]=[CH:27][CH:26]=[CH:25][CH:24]=1)[CH2:6][C:7]1[CH:12]=[CH:11][C:10]([O:13][C:14]2[CH:19]=[C:18]([N:31]3[CH2:36][CH2:35][NH:34][CH2:33][CH2:32]3)[N:17]=[C:16]([NH2:21])[N:15]=2)=[CH:9][CH:8]=1)[CH3:2]Participants
3
Procedure
3-[4-(2-Amino-6-chloro-pyrimidin-4-yloxy)-phenyl]-2-methyl-2-phenoxy-propionic acid ethyl ester and piperazine were reacted, as described in Example 2, Step G, to provide 3-[4-(2-Amino-6-piperazin-1-yl-pyrimidin-4-yloxy)-phenyl]-2-methyl-2-phenoxy-propionic acid ethyl ester, shown below, as a yellow oil.
Sources & evidence
- ORD record
- ord-6c3c7b5a76914c9195a04369323c1254
- Source dataset
- uspto-grants-2013_08
- Patent number
- US08513233B2
Reaction notes
Loading…